Adrian R. Krainer, Director at Stoke Therapeutics, Inc. (STOK), sold 80,944 shares at $26.61 ($2.2M) on 2025-11-14, disclosed to the SEC on 2025-11-18.
Scheduled sale ($2.2M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.61 | 19,790 | $527K | 24.1% |
| 2 | $26.61 | 19,790 | $527K | 24.1% |
| 3 | $27.34 | 20,682 | $565K | 25.9% |
| 4 | $27.34 | 20,682 | $565K | 25.9% |
| Total | $26.98 avg | 80,944 | $2.2M | 100% |
| Filing → |
| STOK | SELL | 2025-11-26 | $2.4M | — | Filing → |